About This Stock More About This StockReadReadReadRead
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
Article By: The Fly
Monday, April 17, 2017 12:52 PM EDT
Shares of drugmaker Incyte (INCY) and mega-cap partner Eli Lilly (LLY) are sliding after the Food and Drug Administration rejected their application for rheumatoid arthritis therapy baricitinib in its current form, due to safety concerns.